Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis

OBJECTIVE: To evaluate salivary interleukin (IL)-1β levels in patients with psoriasis, before and after treatment with tumour necrosis factor (TNF)-α inhibitors. METHODS: In this pilot study, salivary secretions were collected from patients with psoriasis and untreated healthy control subjects at ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganzetti, Giulia, Campanati, Anna, Santarelli, Andrea, Sartini, Davide, Molinelli, Elisa, Brisigotti, Valerio, Di Ruscio, Giulia, Bobyr, Ivan, Emanuelli, Monica, Offidani, Annamaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Gene/Molecular Research on Immune-Mediated Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536539/
https://www.ncbi.nlm.nih.gov/pubmed/27683132
http://dx.doi.org/10.1177/0300060515598902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536539/
https://www.ncbi.nlm.nih.gov/pubmed/27683132
http://dx.doi.org/10.1177/0300060515598902

Ejemplares similares